0% found this document useful (0 votes)
9 views58 pages

Artificial intelligence

Artificial intelligence in health care by Stanford university

Uploaded by

chiranth gowda
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPT, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
9 views58 pages

Artificial intelligence

Artificial intelligence in health care by Stanford university

Uploaded by

chiranth gowda
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPT, PDF, TXT or read online on Scribd
You are on page 1/ 58

MUSCULAR

DYSTROPHY

Dr. Angelo Smith M.D


WHPL
•Causes
• Inheritance
• Dominant genes
• Recessive gene
Depends on the age when symptoms appear,
and the types of symptoms that develop.
•Risk
• Because these are inherited disorders, risk
include a family history of muscular dystrophy
How Many People Are Affected
It is estimated that between 50,000 -250,000
are affected annually. 1 per 3500 live male
births
• Muscular dystrophy is a heterogeneous
group of inherited disorders
recognized by progressive degenerative
muscle weakness and loss of muscle
tissue (started in childhood).
• Affect muscles strength and action.
• Generalized or localized.
• Skeletal muscle and other organs may
involve

• Limitation: Difficulties with walking or Maintaining posture,


Muscle spasms. Neurological, Behavioral, Cardiac, or other
Functional limitations.
Classification
•Sex-linked: DMD, BMD, ED
MD
•Autosomal recessive: LGM
D, infantile FSHD
•Autosomal dominant: FSH
D, distalMD, ocular MD, ocu
lopharyngeal MD.
Duchenne Muscular Dystr
ophy

Guillaume Benjamin Amand Duchenne


(French neurologist, 1860s)
•Etiology
▫single gene def
ect
▫Xp21.2 region
▫absent dystrop
hin
• Most common
• male, Turner
syndrome
• 1:3500 live m
ale birth
• 1/3 new muta
tion
• 65% family hi
story
Clinical manifestation
• Onset : age 3-6 ye
ars
• Progressive weak
ness
• Pseudohypertroph
y of calf muscles
• Spinal deformity
• Cardiopulmonary i
nvolvement
• Mild - moderate M
R
Natural history

• Progress slowly and


continuously
• muscle weakness
▫ lower --> upper ex
tremities
• unable to ambulate:
10 year (7-12)
• death from pulmonar
y/ cardiac failure: 2-3
rd decade
Pseudohypertrhophy of calf muscle, Tip toe gait
forward tilt of pelvis, compensatory lordosis
Disappearance of
lordosis while sitting
DMD: Diagnosis
• Gait
• Absent DTR
• Increase CPK (200x)
• Ober test • Myopathic change in
• Thomas test EMG
• Meyeron sign - child Bx: m. degeneration
slips through truncal • Immunoblotting: Abs
grasp ence dystrophin
• Macroglossia • DNA mutation analys
• Myocardial deterioration is
• IQ ~ 80
Becker Muscular Dystrop
hy

Peter Emil Becker


(German doctor, 1950s)
• Milder version of
DMD
• Etiology
▫single gene defect
▫short arm X chrom
osome
▫altered size & decr
eased amount of d
ystrophin
Clinical features
• Less common
▫ 1: 30000 live male birth
• Less severe
• Family history: atypical MD
• Similar & less severe than DMD
• Onset: age > 7 years
• Pseudohypertrophy of calf
• Equinous and varus foot
• High rate of scoliosis
• Less frequent cardiac involvement
Diagnosis
• The same as DMD
• Increase CPK (<200x)
• Decrease dystrophin and/or altered size
Natural history
▫ Slower progression
▫ ambulate until adolescence
▫ longer life expectancy
Treatment
▫ the same as in DMD
▫ forefoot equinous: plantar release, midfoot dorsal-we
dge osteotomy
Emery-Dreifuss Muscular Dys
trophy
• Etiology
▫ X-linked recessive
▫ Xq28
▫ Emerin protein (in
nuclear membrane)
• Epidemiology
▫ Male: typical phenotype
▫ Female carrier: partial
• Clinical Features
▫ Muscle weakness
▫ Contracture
 Neck extension,
elbow, achillis tendon
Scoliosis: common, low incidence of
progression
Bradycardia, 1st degree AV block 
sudden death
• Natural history
▫1st 10 y: mild
weakness
▫Later: contracture,
cardiac abnormality
•Diagnosis ▫5th-6th decade: can
▫Gower’s sign ambulate
▫Poor prognosis in
▫Mildly/moderately obesity, untreated
elevated CPK equinus
▫EMG: myopathic contractures.
▫Normal dystrophin
Treatment
• Physical therapy
▫ Prevent contracture: neck, elbow, paravertebral
muscles
▫ For slow progress elbow flexion contracture
• Soft tissue contracture
▫ Achillis lengthening, posterior ankle capsulotomy +
anterior transfer of tibialis posterior
• Spinal stabilization
▫ For curve > 40 degrees
• Cardiologic intervention
▫ Cardiac pacemaker
Limb - Girdle Muscular Dystro
phy
•Etiology
▫Autosomal recessive at chromosome
15q
▫Autosomal dominant at 5q
•Epidemiology
▫Common
▫More benign
•Clinical
manifestation
▫Age of onset: 3rd
decade
▫Initial:
pelvic/shoulder m.
(proximal to distal)
▫Similar distribution
as DMD
Hemiatroph
y
•Classification
▫Pelvic girdle type
 common
▫Scapulohumeral
type
 rare
• Diagnosis
▫ Same clinical as
DMD/BMD carriers
▫ Moderately elevated
CPK
▫ Normal dystrophin
•Natural history
▫Slow progression
▫After onset > 20 y:
contracture &
disability
▫Rarely significant
scoliosis

•Treatment
▫Similar to DMD
▫Scoliosis: mild, no Rx.
Fascioscapulohumeral Muscular
Dystrophy
• Etiology • Clinical
▫Autosomal dominant manifestation
▫ Age of onset: late
▫Gene defect (FRG1)
childhood/ early adult
▫Chromosome 4q35 ▫ No cardiac, CNS
• Epidemiology involvement
▫Female > male ▫ Winging scapula
▫ Markedly decreased
shoulder flexion &
abduction
▫ Horizontal clavicles
▫ Rare scoliosis
•Muscle weakness
▫face, shoulder, upper arm

•Sparing
▫Deltoid
▫Distal pectoralis major
▫Erector spinae
• “Popeye”
appearance
▫ Lack of facial mobility
▫ Incomplete eye
closure
▫ Pouting lips
▫ Transverse smile
▫ Absence of eye and
forehead wrinkles

POPEYE ARMS
•Diagnosis
▫PE, muscle biopsy
▫Normal serum CPK
•Natural history •Treatment
▫Slow progression ▫Posterior
▫Face, shoulder m. scpulocostal
 pelvic girdle, fusion/ stabilization
tibialis ant (scapuloplexy)
▫Good life
expectancy
Distal Muscular Dystrophy

• Autosomal dominant trait


• Rare
• Dysferlin (mb prot) defect
• Age of onset: after 45 yrs
• Initial involvement:
intrinsic hands, claves,
tibialis posterior
• Spread proximally
• Normal sensation
Congenital Muscular
Dystrophy
• Etiology
▫ Autosomal recessive
▫ Integrin, fugutin defect
• Epidemiology
▫ Rare
▫ Both male and female
• Classification
▫ Merosin-negative
▫ Merosin-positive
▫ Neuronal migration
 Fukuyama
 Muscle eye-brain
 Wlaker-Warburg
Clinical manifestation

• Stiffness of joint
• Congenital hip
dislocation,
subluxation
• Achillis tendon
contracture,
talipes
equinovarus
• Scoliosis
Diagnosis
Muscle Bx: Perimysial and endomysial fibrosis
Treatment
Physical therapy
Orthosis
Soft tissue release
Osteotomy
Oculopharyngeal Muscular
Dystrophy
• Autosomal dominant
• Age of onset: 3rd decade
• Ptosis in middle life
• Pharyngeal involvement
▫ Dysarthria
▫ Dysphasia
▫ Repetitive regurgitation
▫ Frequently choking
Myotonic Muscular
Dystrophy

HATCHET FACIES
`Classical form' of the disease is seen in
adolescent or early adult life with variable
presenting features.
• Muscular weakness,
•myotonia,
•mental retardation,
•cataract,
•neonatal problems
•18% remain asymptomatic.
Summary
Clinical DMD LGMD FSMD DD CMD

Incidence common less Not Rare Rare


common

Age of 3-6 y 2nd decade 2nd decade 20-77 y At/ after


onset birth

Sex Male Either sex M=F Either sex Both

Inheritance Sex-linked AR, rare AD AD Unknown


recessive AD

Muscle Proximal to Proximal to Face & Distal Generalized


involve. distal distal shoulder to
pelvic

Muscle Leg, hand, Upper ex, Back ext, Proximal -


spread arm, face, calf hip abd,
until late larynx,eye quad
Clinical DMD LGMD FSMD DD CMD
Pseudo 80% < 33% Rare no No
hypertrophy calf

Contracture Common Late Mild, late Mild, late Severe

Scoliosis Common, Late - - ?


Kyphoscoliosis late

Heart Hypertrophy Very rare Very rare Very rare Not


tachycardia observed

Intellectual decrease Normal Normal Normal ?

Course Stead, rapid Slow Insidious benign Steady


Treatment
is generally aimed at
controlling the onset of
symptoms to maximize the
quality of life.

You might also like